Please use this identifier to cite or link to this item:
http://repository.i3l.ac.id/jspui/handle/123456789/154
Title: | Implication of Xxx Silencing on Epatocellular Carcinoma Drug Esponse through NFkB Signaling Pathway |
Authors: | Karyadi, Azrina Saraswati |
Keywords: | human genome Non-coding RNA NFkB gene expression |
Issue Date: | 19-Dec-2019 |
Publisher: | Indonesia International Institute for Life Sciences |
Series/Report no.: | BM 19-014;T201912014 |
Abstract: | Non-coding RNAs, which made up 98% of the human genome, have immense regulatory influence in cellular functionality that have not yet been fully explored. A study conducted by Prof. Vinay Tergaongkar’s laboratory identified an important lncRNA, XXX, which deregulates NFkB biology in cancer by sustaining covalent modification of p65, thereby regulating genome-wide occupancy of p65 on targets essential to inflammation, cancer progression, and CSC maintenance. HCC made up 90% of the primary liver cancer cases, and its progression and malignancy revolve around the CSC model. Being attributed to various inflammatory etiologies, dysregulation of NFkB is a major hallmark to its development. This study explores the breadth of XXX influence on NFkB signaling in HCC by analyzing its impact of NFkB’s target gene expression, resulting stemness phenotype alterations, and drug resistance. |
URI: | http://repository.i3l.ac.id/jspui/handle/123456789/154 |
Appears in Collections: | Biomedicine |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
T201912014_BM_Azrina Saraswati Karyadi_15010005.pdf Restricted Access | Full text | 7.26 MB | Adobe PDF | View/Open Request a copy |
Cover.pdf | Cover | 36.42 kB | Adobe PDF | View/Open |
Abstract.pdf | Abstract | 48.12 kB | Adobe PDF | View/Open |
Chapter 1.pdf | Chapter 1 | 67.83 kB | Adobe PDF | View/Open |
References.pdf | References | 138.42 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.